In addition, PTK2 is overexpressed in many major cancer types, including lung cancer, hepatocellular carcinoma, and lymphocytic leukemia (Weisser et al., 2014; Fan et al., 2019). This evidence concerns the gene PTK2 and hepatocellular carcinoma.